Christopher Guttman-McCabe insider trades: Anterix (ATEX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christopher reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 25, 2026 | ATEX | ↓ Sell | 23,439 | $92.36 | $2.2M | Direct | Aug 27, 2026 (2d) |
| Jun 15, 2026 | ATEX | ↓ Sell | 122,852 | $81.75 | $10.0M | Direct | Aug 14, 2026 (60d) |
| Jun 15, 2026 | ATEX | ↓ Sell | 91,437 | $82.46 | $7.5M | Direct | Jun 17, 2026 (2d) |
| Nov 25, 2022 | ATEX | ↓ Sell | 8,332 | $36.20 | $302K | Direct | Nov 28, 2022 (3d) |
| Feb 18, 2021 | ATEX | ↓ Sell | 7,538 | $44.26 | $334K | Direct | Feb 19, 2021 (1d) |
| Dec 16, 2020 | ATEX | ↓ Sell | 1,590 | $29.75 | $47K | Direct | Dec 16, 2020 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ATEX insiders
Open-market trades in the last 12 months
About Christopher Guttman-McCabe's insider trades
Christopher Guttman-McCabe is Chief Reg & Comm Officer at Anterix (ATEX). Since Dec 16, 2020, Christopher has reported no open-market purchases and 6 sales worth $20.4M on SEC Form 4. In the last 12 months: 3 sales ($19.7M).
Their filings also include shares withheld for taxes (14 filings), grants and awards (7 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATEX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.